Clinical Trials Search Results

Search for

in

Accepting Participants (1)
In Progress (1)

Showing 1-1 of 1

Sorted By:

A-Z
Z-A

Previous Next

AMG 552 20210096 Bema: A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab plus Chemotherapy versus Placebo plus Chemotherapy in Subjects with Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer with FGFR2b Overexpression (FORTITUDE-101)
Objective: to compare efficacy of bemarituzumab combined with oxaliplatin and 5-fluorouracil (5-FU) (mFOLFOX6) to placebo plus mFOLFOX6 as assessed by overall survival (OS).

Previous Next

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.